AGENT FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY BOWEL DISEASE

Disclosed is an agent for the prevention or treatment of inflammatory bowel disease, which comprises as the active ingredient a polypeptide that has a sequence being at least 70% identical to that of human paraoxonase and that has at least one activity selected from the group consisting of lactonase...

Full description

Saved in:
Bibliographic Details
Main Authors MASUDA, DAISUKE, TANAKA, ISSEI, NARITA, MASAKUNI
Format Patent
LanguageEnglish
French
Japanese
Published 24.03.2011
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Disclosed is an agent for the prevention or treatment of inflammatory bowel disease, which comprises as the active ingredient a polypeptide that has a sequence being at least 70% identical to that of human paraoxonase and that has at least one activity selected from the group consisting of lactonase activity, paraoxonase activity, allyl esterase activity, and active oxygen-consuming activity. L'invention porte sur un agent pour la prévention ou le traitement d'une maladie inflammatoire des intestins, l'agent comprenant comme ingrédient actif un polypeptide qui a une séquence qui est d'au moins 70 % identique à celle de la paraoxonase humaine, et qui a au moins une activité sélectionnée parmi le groupe comprenant l'activité de lactonase, l'activité de paraoxonase, l'activité d'estérase d'allyle et l'activité de consommation d'oxygène actif.
Bibliography:Application Number: WO2010JP66042